LLY stock has taken a hit recently, and it’s all tied to a major move by CVS Health. In a bold decision, CVS announced it would be dropping Eli Lilly’s Zepbound from its formulary. This change has sparked concerns among investors.
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
CEJOF stock jumps to $9.41 on 24 Feb 2026; we analyze the oversold bounce, valuation and Meyka AI forecasts for near-term upside
In 2025, Alphabet is emerging not just as a software and internet giant, but as a serious player in the global AI‑chip arms race. Analysts now believe that Alphabet’s in‑house silicon, especially its custom AI chips or Tensor Processing Units (TPUs), could underlie a market opportunity worth up to $900 billion. If that forecast holds, the…
KATX stock sees 28.34M share volume on 25 Feb 2026 at USD 1.05; analysis, Meyka AI grade and forecasts for traders
HAWEL stock trades $21.04 on PNK; short-term oversold bounce possible to $21.25, watch volume and 50-day average
AGNC stock closes at $11.66; earnings due Jan 26. Meyka AI forecast and grade for AGNC stock outlook.
Coinbase Stock took a hit after analysts at Compass Point downgraded it to Sell from Neutral. This change came with a price target drop from $330 to $248, signaling a 21% decline from its recent close. Investors watching the stock market need to know why this happened and what it means. Continue Reading on Meyka…